This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Court voids Merck Fosamax patent, aids cheaper generic
A federal appeals court invalidated Merck's once weekly Fosamax patent, opening potential generic competition by 2008. The ruling, amid Vioxx scrutiny and Zocor pressures, sent Merck shares down and raised questions about future drug revenues and pipeline.
MENTIONED IN THIS ARTICLE
Merck
Trenton
N.J
Merck & Co
Federal Securities and Exchange Commission
U.S. Court of Appeals For
Federal Circuit
Washington, D.C
United States
Whitehouse Station
N.j.-Based
Tony Plohoros
Court of Appeals
Plohoros
New York Stock Exchange
Barbara Ryan
Deutsche Bank Securities Inc
Vioxx
Zocor
Ryan
Albert Rauch
A. G. Edwards & Sons Inc
Rauch
Tim Anderson
Prudential Financial
Switzerland
Roche Group
U.S. District Court
Delaware
SEC